Back
ESC Premium Access

Adherence to international guidelines on diuretic treatment in heart failure based on congestive signs in 43,744 patients from SwedeHF

Session: Pharmacologic approaches in HF: could we do better?
Topic: Pharmacologic therapy
Speaker: Doctor P. Paren (Gothenburg, SE)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Doctor Par Paren

Sahlgrenska University Hospital, Gothenburg (Sweden)
0 follower

9 more presentations in this session

The risk of atrial fibrillation with ivabradine treatment: A meta-analysis with trial sequential analysis of over 40000 patients

Speaker: Associate Professor I. Tanboga (Istanbul, TR)

Access
Abstract
Slides
Video
Thumbnail

Differential impacts of digoxin modulated by volume status on one-year mortality in patients with acute heart failure

Speaker: Doctor W. Wang (Taipei, TW)

Access
Abstract
Slides
Video
Thumbnail

Dosage-dependent association between betablocker therapy with Carvedilol or Metoprolol and the risk of appropriate ICD therapy in primary prevention ICD patients.

Speaker: Doctor A. Huth Ruwald (Copenhagen, DK)

Access
Abstract
Slides
Video
Thumbnail

The cost-effectiveness of sacubitril/valsartan (LCZ696) in the treatment of patients with heart failure with reduced ejection fraction in Norway

Access
Slides
Video
Thumbnail

Effect of in-hospital treatment on short-term mortality of elderly versus non-elderly patients hospitalized for acute heart failure

Speaker: Doctor S. Katsanos (Athens, GR)

Access
Abstract
Thumbnail

Access the full session

Pharmacologic approaches in HF: could we do better?

Speakers: Doctor P. Paren, Associate Professor I. Tanboga, Doctor W. Wang, Doctor A. Huth Ruwald, Doctor S. Katsanos
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb